Cytokeratin 19 Antikörper
-
- Target Alle Cytokeratin 19 (KRT19) Antikörper anzeigen
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Cytokeratin 19 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Spezifität
- Reacts with human Cytokeratin 19
- Kreuzreaktivität (Details)
- Does not react with hepatocytes and hepatocellular carcinoma.
- Aufreinigung
- Purified
- Immunogen
- Cytoskeletal preparation of human bladder carcinoma cell line T24
- Klon
- RCK108
- Isotyp
- IgG1
- Top Product
- Discover our top product KRT19 Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: FC (1:100 - 1:200), ICC, IHC - F (1:100 - 1:200), IHC-P (10 μg/mL), WB (1:100 - 1:1000)
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS, 0.09 % Sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles. Store undiluted.
-
- Target
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
- Andere Bezeichnung
- Cytokeratin 19 (KRT19 Produkte)
- UniProt
- P08727
-